University of Sussex Breaking News Legend, Janssen Will Invest $150M to Expand Carvykti Manufacturing in Europe BMS's Breyanzi Gains European Approval as Third-Line Treatment for Follicular Lymphoma RedHill Biopharma to Launch Phase II Trial of Crohn's Disease Drug in Biomarker-Defined Population In Brief This Week: Count Me In, TeleRare Health, VolitionRx, Ascentage, Atsena, ClearNote Health PDS Biotech Cleared to Begin Trial of Immunotherapy Combo in MUC1-Positive Colorectal Cancer MeiraGTx, Hologen Tackle CNS Disorders With AI Drug Development Joint Venture
